Composition :

Each MUCOSTA Tablet contains 100 mg of rebamipide.

• Gastric ulcer in combination with offensive factor inhibitors (Proton Pump Inhibitors, Anticholinergic,

H2-antagonist).

• Gastritis

Patients with a history of hypersensitivity to any ingredient of this drug.

• Gastric ulcers : In combination with offensive factor inhibitors the usual adult dosage of MUCOSTA Tablets is one tablet (100 mg of rebamipide) orally three times daily, in the morning, in the evening, and before  bedtime.

• Gastritis : The usual adult dosage of MUCOSTA Tablets is one tablet (100 mg of rebamipide) orally three times daily.

Special care is required in elderly patients to minimize the risk of gastrointestinal disorders, because these patients may be physiologically more sensitive to this drug than younger patients.

The safety of this drug in low birth weight infants, newborns, suckling infants, and children has not been established. (Clinical experience is insufficient)

Patients should be instructed not to ingest any portion of the press-through package (PTP) (There have been reports that the sharp edges of the sheet can cut or penetrate the esophageal mucosa if accidentally ingested, resulting in mediastinitis or other serious complications).

• Boxes of 10 blister of 10 tablets

• Reg. No. DKL 0518707017A1